Effects of Liposomal Nanoparticles-Mediated miR-126 on Cervical Cancer Cells via Anti-Programmed Cell Death-1/Programmed Death Ligand 1 (PD-1/PD-L1) Signaling

Xu, Minjuan; Huang, Jun; Wang, Liefeng

doi:10.1166/sam.2021.4003

Cited by 3 publications

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Specific and non-specific markers of cardiac injuries, such as LDH, CK-MB, cTn-I, BNP, and cTn-T, are released from the cardiac tissue when myocardial cells become damaged due to necrosis and the permeability of the cell membrane increases. Because cardiac tissue damage happens in response to toxic exposure, these enzymes enter the bloodstream, thus increasing their concentration in the serum [ 8 , 39 ]. Thus, serum enzymes such as CK-MB, BNP AST, ALT, and LDH are known and well-validated diagnostic markers for cardiotoxicity [ 38 ].…”

Section: Discussionmentioning

confidence: 99%

Farnesol Protects against Cardiotoxicity Caused by Doxorubicin-Induced Stress, Inflammation, and Cell Death: An In Vivo Study in Wistar Rats

et al. 2022

View full text Add to dashboard Cite

Doxorubicin (DOXO) is an antineoplastic drug that is used extensively in managing multiple cancer types. However, DOXO-induced cardiotoxicity is a limiting factor for its widespread use and considerably affects patients’ quality of life. Farnesol (FSN) is a sesquiterpene with antioxidant, anti-inflammatory, and anti-tumor properties. Thus, the current study explored the cardioprotective effect of FSN against DOXO-induced cardiotoxicity. In this study, male Wistar rats were randomly divided into five groups (n = 7) and treated for 14 days. Group I (Control): normal saline, p.o. daily for 14 days; Group II (TOXIC): DOXO 2.4 mg/kg, i.p, thrice weekly for 14 days; Group III: FSN 100 mg/kg, p.o. daily for 14 days + DOXO similar to Group II; Group IV: FSN 200 mg/kg, p.o. daily for 14 days + DOXO similar to Group II; Group V (Standard): nifedipine 10 mg/kg, p.o. daily for 14 days + DOXO similar to Group II. At the end of the study, animals were weighed, blood was collected, and heart-weight was measured. The cardiac tissue was used to estimate biochemical markers and for histopathological studies. The observed results revealed that the FSN-treated group rats showed decrease in heart weight and heart weight/body weight ratio, reversed the oxidative stress, cardiac-specific injury markers, proinflammatory and proapoptotic markers and histopathological aberrations towards normal, and showed cardioprotection. In summary, the FSN reduces cardiac injuries caused by DOXO via its antioxidant, anti-inflammatory, and anti-apoptotic potential. However, more detailed mechanism-based studies are needed to bring this drug into clinical use.

show abstract

Section: Discussionmentioning

confidence: 99%

Farnesol Protects against Cardiotoxicity Caused by Doxorubicin-Induced Stress, Inflammation, and Cell Death: An In Vivo Study in Wistar Rats

et al. 2022

View full text Add to dashboard Cite

show abstract

Nanomaterials in Cancer Immunotherapy: A Spotlight on Breast Cancer

Ahmad

Abdel-Wahab

et al. 2023

sci adv mater

View full text Add to dashboard Cite

Breast cancer (BC) is one of the primary causes of death among females worldwide. It can affect a woman at any age after puberty, but the risk of developing the disease increases with age. An early diagnosis and the implementation of an appropriate therapeutic strategy are the two most essential aspects in assuring a favorable prognosis for patients diagnosed with any cancer. There has been significant development in cancer immunotherapy over the past few years. It is among the most effective approaches to fighting cancer and boosts the immune system. In the preclinical setting, immunotherapy using checkpoint blockade antibodies and antigen receptor T cells has shown promising results in BC. Despite this, developing safe and effective immunotherapy against breast cancer is challenging because several novel antigens are poorly immunogenic. Regrettably, conventional immunotherapy confronts further obstacles, such as its inability to trigger the anti-tumor response sufficiently. Most tumors have low immunogenicity due to their origin in healthy cells, making it difficult for the immune system to recognize them as foreign invaders. Additionally, the clinical use of immunotherapy for BC has experienced significant drawbacks, including poor immune responses due to insufficient antigen delivery to the immune cells and uncontrolled immune system regulation, which can promote autoimmunity and nonspecific inflammation. To address these challenges, nanomaterial-based immunotherapy has recently emerged as a potent tool against BC. Scientists have been enthralled by the potential of nanomaterial in BC immunotherapy for decades due to its significant benefits over traditional immunotherapy. Over the past few decades, there has been a considerable increase in the research and application of nanomaterial-based antigens/adjuvants in BC immunotherapy. This review focuses on current advances in BC immunotherapy strategies by focusing on recent breakthroughs in nano immunotherapy.

show abstract

Cytotoxic Activity of Vitex leucoxylon Aqueous Leaf Extract Against A549 and NCIH-460 Lung Cancer Cell Lines

Shaikh,

Nasreen,

Mahnashi

et al. 2023

sci adv mater

View full text Add to dashboard Cite

The primary goal of this research was to determine the cytotoxic potential of an aqueous extract of Vitex leucoxylon aerial parts on the lung cancer A549 and non-small cell lung cancer NCIH-460 cell lines. The Soxhlet apparatus and distilled water were used for the extraction of the medicinal plant. The MTT in vitro assay was used to test the compounds for anticancer activity against two different lines of lung cancer. The cytotoxic activity of V. leucoxylon in the present study was very substantial as measured by its ability to suppress the growth of both cell lines. The IC50 values for A549 and NCI-H460 were determined to be 315.57 and 560.48 μg/mL, respectively. The current research confirmed that V. leucoxylon’s aqueous leaf extract possessed potent anticancer properties. Both the cancer cell lines were significantly inhibited in their ability to differentiate when subjected to the MTT assay. In future, flavonoid compounds in the aqueous extract need to be purified, characterized, and structurally elucidated for in-vivo studies, which could lead to the creation of new drug candidates.

show abstract

Effects of Liposomal Nanoparticles-Mediated miR-126 on Cervical Cancer Cells via Anti-Programmed Cell Death-1/Programmed Death Ligand 1 (PD-1/PD-L1) Signaling

Cited by 3 publications

References 18 publications

Farnesol Protects against Cardiotoxicity Caused by Doxorubicin-Induced Stress, Inflammation, and Cell Death: An In Vivo Study in Wistar Rats

Farnesol Protects against Cardiotoxicity Caused by Doxorubicin-Induced Stress, Inflammation, and Cell Death: An In Vivo Study in Wistar Rats

Nanomaterials in Cancer Immunotherapy: A Spotlight on Breast Cancer

Cytotoxic Activity of Vitex leucoxylon Aqueous Leaf Extract Against A549 and NCIH-460 Lung Cancer Cell Lines

Contact Info

Product

Resources

About